| 1 | [SID22415523] | Active | Potency | 2.5119 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 2 | [SID22415523] | Active | Potency | 5.3233 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): Hit Validation in Primary Screen [AID652023, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | Potency | 5.3233 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): Hit Validation in Primary Screen | | AID | 652023 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 3 | [SID22415523] | Active | Potency | 5.3233 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): Hit Validation in Primary Screen [AID652023, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | Potency | 5.3233 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): Hit Validation in Primary Screen | | AID | 652023 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 4 | [SID22415523] | Active | Potency | 10 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 5 | [SID22415523] | Active | Potency | 10 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 6 | [SID22415523] | Active | Potency | 11.2202 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 7 | [SID22415523] | Active | Potency | 12.5893 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 8 | [SID22415523] | Active | Potency | 12.5893 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 9 | [SID22415523] | Active | Potency | 15.8489 | qHTS of TDP-43 Inhibitors [AID652104, Type: confirmatory] | TAR DNA-binding protein 43 [gi:20140568] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS of TDP-43 Inhibitors | | AID | 652104 | | BioAssay type | confirmatory | | Target | TAR DNA-binding protein 43 [gi:20140568] | | PubMed | | | Data Table |  |
|
| 10 | [SID22415523] | Active | Potency | 17.7828 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 11 | [SID22415523] | Active | Potency | 22.3872 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 12 | [SID22415523] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID22415523] | Active | Potency | 28.1838 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 14 | [SID22415523] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID22415523] | Active | | | Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen [AID1456, Type: other] | electroneutral potassium-chloride cotransporter KCC2 [Homo sapiens] [gi:12003227] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | BioAssay | Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen | | AID | 1456 | | BioAssay type | other | | Target | electroneutral potassium-chloride cotransporter KCC2 [Homo sapiens] [gi:12003227] | | PubMed | | | Data Table |  |
|
| 16 | [SID22415523] | Active | | | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): DTNB Assay [AID652256, Type: other] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): DTNB Assay | | AID | 652256 | | BioAssay type | other | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 17 | [SID22415523] | Active | | | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): DTNB Assay [AID652256, Type: other] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): DTNB Assay | | AID | 652256 | | BioAssay type | other | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 18 | [SID22415523] | Active | | | uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay [AID463190, Type: screening] | TPA: Tim10p [Saccharomyces cerevisiae S288c] [gi:285809906] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay | | AID | 463190 | | BioAssay type | screening | | Target | TPA: Tim10p [Saccharomyces cerevisiae S288c] [gi:285809906] | | PubMed | | | Data Table |  |
|
| 19 | [SID22415523] | Active | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 20 | [SID22415523] | Active | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 21 | [SID22415523] | Active | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 22 | [SID22415523] | Active | | | Development of Subtype-specific Activators of the GIRK family of Potassium Channels (mGlu8_nonGIRK_Counterscreen) [AID623868, Type: other] | Metabotropic glutamate receptor 8 [gi:2495080] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | BioAssay | Development of Subtype-specific Activators of the GIRK family of Potassium Channels (mGlu8_nonGIRK_Counterscreen) | | AID | 623868 | | BioAssay type | other | | Target | Metabotropic glutamate receptor 8 [gi:2495080] | | PubMed | | | Data Table |  |
|
| 23 | [SID22415523] | Active | | | Development of Subtype-specific Activators of the GIRK family of Potassium Channels (mGlu8_nonGIRK_Counterscreen) [AID623868, Type: other] | Metabotropic glutamate receptor 8 [gi:2495080] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | BioAssay | Development of Subtype-specific Activators of the GIRK family of Potassium Channels (mGlu8_nonGIRK_Counterscreen) | | AID | 623868 | | BioAssay type | other | | Target | Metabotropic glutamate receptor 8 [gi:2495080] | | PubMed | | | Data Table |  |
|
| 24 | [SID22415523] | Active | | | Development of Subtype-specific Activators of the GIRK family of Potassium Channels (mGlu8_nonGIRK_Counterscreen) [AID623868, Type: other] | Metabotropic glutamate receptor 8 [gi:2495080] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Active | | BioAssay | Development of Subtype-specific Activators of the GIRK family of Potassium Channels (mGlu8_nonGIRK_Counterscreen) | | AID | 623868 | | BioAssay type | other | | Target | Metabotropic glutamate receptor 8 [gi:2495080] | | PubMed | | | Data Table |  |
|
| 25 | [SID22415523] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 26 | [SID22415523] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 27 | [SID22415523] | Inactive | Potency | 7.3753 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | Potency | 7.3753 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID22415523] | Inactive | Potency | 9.285 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | Potency | 9.285 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID22415523] | Inactive | Potency | 20.7491 | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 [AID2288, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | Potency | 20.7491 [uM] | | BioAssay | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 | | AID | 2288 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID22415523] | Inactive | Potency | 22.3872 | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) [AID485290, Type: confirmatory] | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) | | AID | 485290 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] | | PubMed | | | Data Table |  |
|
| 31 | [SID22415523] | Inactive | Potency | 31.6228 | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 32 | [SID22415523] | Inactive | Potency | | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624288, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624288 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 33 | [SID22415523] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). [AID1861, Type: screening] | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). | | AID | 1861 | | BioAssay type | screening | | Target | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] | | PubMed | | | Data Table |  |
|
| 34 | [SID22415523] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). [AID1861, Type: screening] | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). | | AID | 1861 | | BioAssay type | screening | | Target | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] | | PubMed | | | Data Table |  |
|
| 35 | [SID22415523] | Inactive | IC50 | | Image-Based HTS for Selective Antagonists of GPR35 [AID2058, Type: confirmatory] | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Image-Based HTS for Selective Antagonists of GPR35 | | AID | 2058 | | BioAssay type | confirmatory | | Target | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] | | PubMed | | | Data Table |  |
|
| 36 | [SID22415523] | Inactive | IC50 | | Image-Based HTS for Selective Antagonists of GPR35 [AID2058, Type: confirmatory] | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Image-Based HTS for Selective Antagonists of GPR35 | | AID | 2058 | | BioAssay type | confirmatory | | Target | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] | | PubMed | | | Data Table |  |
|
| 37 | [SID22415523] | Inactive | IC50 | | Image-Based HTS for Selective Antagonists of GPR35 [AID2058, Type: confirmatory] | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Image-Based HTS for Selective Antagonists of GPR35 | | AID | 2058 | | BioAssay type | confirmatory | | Target | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] | | PubMed | | | Data Table |  |
|
| 38 | [SID22415523] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 39 | [SID22415523] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 40 | [SID22415523] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 41 | [SID22415523] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 42 | [SID22415523] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 43 | [SID22415523] | Inactive | Potency | | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): Counterassay in Glutathione Reductase (GR) [AID652020, Type: confirmatory] | glutathione reductase [Homo sapiens] [gi:31829] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): Counterassay in Glutathione Reductase (GR) | | AID | 652020 | | BioAssay type | confirmatory | | Target | glutathione reductase [Homo sapiens] [gi:31829] | | PubMed | | | Data Table |  |
|
| 44 | [SID22415523] | Inactive | Potency | | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): Counterassay in Glutathione Reductase (GR) [AID652020, Type: confirmatory] | glutathione reductase [Homo sapiens] [gi:31829] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): Counterassay in Glutathione Reductase (GR) | | AID | 652020 | | BioAssay type | confirmatory | | Target | glutathione reductase [Homo sapiens] [gi:31829] | | PubMed | | | Data Table |  |
|
| 45 | [SID22415523] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 46 | [SID22415523] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 47 | [SID22415523] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 48 | [SID22415523] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 49 | [SID22415523] | Inactive | | | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP) [AID1471, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP) | | AID | 1471 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 50 | [SID22415523] | Inactive | | | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP) [AID1471, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 22415523 | | CID | 2281752 | | Outcome | Inactive | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP) | | AID | 1471 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|